SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lindh Anders)
 

Sökning: WFRF:(Lindh Anders) > Anal carcinoma - Su...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004307naa a2200565 4500
001oai:DiVA.org:umu-99788
003SwePub
008150212s2014 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:6390a24b-d036-4a01-a2ce-5e22509b71f5
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-997882 URI
024a https://doi.org/10.1016/j.radonc.2014.10.0022 DOI
024a https://lup.lub.lu.se/record/49084872 URI
040 a (SwePub)umud (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Leon, Otiliau Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)med-ole
2451 0a Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
264 1b Elsevier BV,c 2014
338 a print2 rdacarrier
520 a Objective:To evaluate treatment outcome in a large population-based cohort of patients with anal cancer treated according to Nordic guidelines.Material:Clinical data were collected on 1266 patients with anal squamous cell carcinoma diagnosed from 2000 to 2007 in Sweden, Norway and Denmark. 886 of the patients received radiotherapy 5464 Gy with or without chemotherapy (5-fluorouracil plus cisplatin or mitomycin). according to different protocols, stratified by tumor stage.Results:High age, male gender, large primary tumor, lymph node metastases, distant metastases, poor performance status, and non-inclusion into a protocol were all independent factors associated with worse outcome. Among patients treated according to any of the protocols, the 3-year recurrence-free survival ranged from 63% to 76%, with locoregional recurrences in 17% and distant metastases in 11% of patients. The highest rate of inguinal recurrence (11%) was seen in patients with small primary tumors, treated without inguinal irradiation.Conclusions:Good treatment efficacy was obtained with Nordic, widely implemented, guidelines for treatment of anal cancer. Inguinal prophylactic irradiation should be recommended also for small primary tumors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a Anal cancer
653 a Radiotherapy
653 a Chemoradiotherapy
700a Guren, Marianne4 aut
700a Hagberg, Oskaru Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)mats-oha
700a Glimelius, Bengt4 aut
700a Dahl, Olav4 aut
700a Havsteen, Hanne4 aut
700a Naucler, Gisela4 aut
700a Svensson, Christer4 aut
700a Tveit, Kjell Magne4 aut
700a Jakobsen, Anders4 aut
700a Pfeiffer, Per4 aut
700a Wanderas, Eva4 aut
700a Ekman, Tor4 aut
700a Lindh, Birgittau Umeå universitet,Institutionen för strålningsvetenskaper4 aut0 (Swepub:umu)bili0014
700a Balteskard, Lise4 aut
700a Frykholm, Gunilla4 aut
700a Johnsson, Andersu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)onk-ajo
710a Tumörmikromiljöb Sektion I4 org
773t Radiotherapy and Oncologyd : Elsevier BVg 113:3, s. 352-358q 113:3<352-358x 0167-8140x 1879-0887
856u http://www.ncbi.nlm.nih.gov/pubmed/25499203?dopt=Abstracty FULLTEXT
856u http://dx.doi.org/10.1016/j.radonc.2014.10.002y FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-99788
8564 8u https://doi.org/10.1016/j.radonc.2014.10.002
8564 8u https://lup.lub.lu.se/record/4908487

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy